Vrtx stock price.

Feb 10, 2023 · Shares of Vertex Pharmaceuticals (VRTX-0.05%) ... Vertex's future looks a little brighter than its stock price suggests. Shares are currently trading at around 23.1 times last year's earnings.

Vrtx stock price. Things To Know About Vrtx stock price.

Nov 29, 2023 · According to the issued ratings of 19 analysts in the last year, the consensus rating for Vertex Pharmaceuticals stock is Moderate Buy based on the current 7 hold ratings and 12 buy ratings for VRTX. The average twelve-month price prediction for Vertex Pharmaceuticals is $376.13 with a high price target of $456.00 and a low price target of $296.00. This 72% rise for VRTX stock since late 2018 can primarily be attributed to 1. Vertex Pharmaceuticals’ revenue rose a significant 253% to $8.4 billion over the last twelve months, compared to $2 ...Dec 4, 2023 · VRTX currently has a PEG ratio of 2.10. Another notable valuation metric for GSK is its P/B ratio of 4.69. Investors use the P/B ratio to look at a stock's market value versus its book value ... View Medical Properties Trust, Inc MPW investment & stock information. Get the latest Medical Properties Trust, Inc MPW detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Dec 1, 2023 · According to 25 stock analysts, the average 12-month stock price forecast for VRTX stock stock is $372.96, which predicts a decrease of -0.18%. The lowest target is $245 and the highest is $456. On average, analysts rate VRTX stock stock as a buy.

Share prices & stock markets; »; Vertex Pharmaceuticals Inc Com Stk; »; Vertex Pharmaceuticals Inc Share price. Vertex Pharmaceuticals Inc (VRTX) Com Stk. Sell ...Find the latest Virpax Pharmaceuticals, Inc. (VRPX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Oct 2, 2023 · The lower the Forward P/E, the cheaper the stock. VRTX’s price/book is 5.96. Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on ...

The FDA grants priority review to Vertex (VRTX)/CRISPR's (CRSP) filings for exa-cel in SCD, with a final decision expected in December.VRTX stock price: 369.95: VRTX RSI: 54.58: Extremely Overbought: 54.58. Extremely Oversold: Also see: VRTX Market Cap History VRTX Shares Outstanding History VRTX YTD Return VRTX DMA VRTX MACD VRTX Technical Analysis. Technical Analysis News: Sandvik Breaks Above 200-Day Moving Average - Bullish for SDVKYStock analysis for Vertex Pharmaceuticals Inc (VRTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, cash flow, balance sheet, and market outlook for the second quarter of 2023.

Insider Sell Alert: EVP and CMO Carmen Bozic Sells 5,650 Shares of Vertex Pharmaceuticals Inc (VRTX) (GuruFocus.com) Nov-16-23 07:05PM. Analyst Report: Vertex Pharmaceuticals Incorporated. (Morningstar Research) 04:06PM. Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval.

Find the latest Intel Corporation (INTC) stock quote, history, news and other vital information to help you with your stock trading and investing.

Price as of November 24, 2023, 1:00 p.m. ET ... (VRTX-0.05%) skyrocketed 31%. So far in 2023, the stock is up nearly 20%. ... Here's why Vertex stock is an even better buy now thanks to AbbVie ...VRTX Vertex Pharmaceuticals Incorporated Stock Price & Overview 56.98K followers $351.00 3.96 ( +1.14%) 4:00 PM 11/29/23 NASDAQ | $USD | Post-Market: …Price as of November 24, 2023, 1:00 p.m. ET ... (VRTX-0.05%) skyrocketed 31%. So far in 2023, the stock is up nearly 20%. ... Here's why Vertex stock is an even better buy now thanks to AbbVie ...VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Mar 20, 2023 · Click here to see why VRTX stock is a Buy. ... The stock price has ranged from a 52-week low of $233.01 to a 52-week high of $325.19. Vertex closed on March 17, 2023, at $295.77. That gave it a PE ...

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Webull offers VRTX Ent Holdg (VRTX) historical stock prices, in-depth market analysis, NASDAQ: VRTX real-time stock quote data, in-depth charts, free VRTX ...A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Click here to see why VRTX stock is a Buy. ... The stock price has ranged from a 52-week low of $233.01 to a 52-week high of $325.19. Vertex closed on March 17, 2023, at $295.77. That gave it a PE ...Find the latest Vertex Pharmaceuticals Incorpor (VRTX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceGet the latest Vertex Pharmaceuticals Incorporated (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move - November 7, 2023 7:05 pm EST Leave a Reply Cancel reply Your email address will not be published.

Vertex Pharmaceuticals (VRTX) closed at $317.27 in the latest trading session, marking a -1.8% move from the prior day. This change lagged the S&P 500's 1.05% gain on the day. Elsewhere, the Dow ...VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move - November 7, 2023 7:05 pm EST; Palantir Technology Price Prediction 2023-2025: Can It Rise More? - November 7, 2023 3:02 pm EST; Leave a Reply Cancel reply. Your email address will not be published. Required fields are marked * Comment *

Nov 29, 2023 · According to the issued ratings of 19 analysts in the last year, the consensus rating for Vertex Pharmaceuticals stock is Moderate Buy based on the current 7 hold ratings and 12 buy ratings for VRTX. The average twelve-month price prediction for Vertex Pharmaceuticals is $376.13 with a high price target of $456.00 and a low price target of $296.00. About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Vertex Pharmaceuticals Incorporated Common Stock (VRTX ... Nov 17, 2023 · Find out why VRTX stock is a Buy. ... Morningstar set a far more conservative Fair Value Estimate of $314, which is substantially below the current market price of VRTX. Reply Like (3) c. chipb. Vertex Pharmaceuticals (VRTX) Stock Price Performance. Vertex Pharmaceuticals (VRTX) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. Previous Close. 351.00. Open. 352.79.VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move - November 7, 2023 7:05 pm EST; Palantir Technology Price Prediction 2023-2025: Can It Rise More? - November 7, 2023 3:02 pm EST; Leave a Reply Cancel reply. Your email address will not be published. Required fields are marked * Comment *The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.

The biopharmaceutical company has multiple catalysts that could boost its share price further. Vertex Pharmaceuticals ( VRTX -0.16% ) is a lower-risk biotech stock to consider, as well.

According to 25 stock analysts, the average 12-month stock price forecast for VRTX stock stock is $372.96, which predicts an increase of 6.21%. The lowest target is $245 and the highest is $456. On average, analysts rate VRTX stock stock as a buy.

Vertex Pharmaceuticals Incorporated (VRTX) stock is trading at $348.85 as of 3:19 PM on Monday, Dec 4, a decline of -$2.32, or -0.66% from the previous closing …GSK currently has a forward P/E ratio of 9.38, while VRTX has a forward P/E of 23.29. We also note that GSK has a PEG ratio of 1.74. This metric is used similarly to …vrtx.com: Footnotes ... $20M in cash and provided an additional $20M in cash in exchange for a convertible note that Vertex can cash in for stock. Vertex also promised to pay up to $275M in milestone payments. ... By 2015 the annual price of Kalydeco had been increased to more than $300,000 per patient.See the latest Vertex Pharmaceuticals Inc stock price (VRTX:XWBO), related news, valuation, dividends and more to help you make your investing decisions.Oct 12, 2023 · In late September, Abrahams raised his price target on VRTX stock to 348 from 343. But he kept his sector perform rating on shares, noting, the "reward/risk still seems balanced here." Get the latest Vertex Pharmaceuticals Incorporated (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...The latest price target for . Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Stifel on Wednesday, November 22, 2023.The analyst firm set a price target for 373.00 expecting VRTX to rise to ...Those risks and uncertainties include, among other things, that data from the company's development programs may not support registration or further development of its compounds due to safety, efficacy or other reasons, and other risks listed under the heading “Risk Factors” in Vertex 's most recent annual report filed with the Securities and …Complete Vertex Pharmaceuticals Inc. stock information by Barron's. View real-time VRTX stock price and news, along with industry-best analysis. The VRTX stock price slipped in after-hours trading, but it was up over 10% in the week and 19% for the year leading up to earnings. If I was an investor, I’d be looking into the reason why.Price is a widely used stock evaluation measure. Find the latest Price for Vertex Pharmaceuticals (VRTX)Aug 9, 2023 · Vertex Pharmaceuticals. Market Cap. $91B. Today's Change. (-1.23%) -$4.38. Current Price. $350.44. Price as of December 1, 2023, 3:23 p.m. ET. You’re reading a free article with opinions that ...

Get the latest Vertex Pharmaceuticals Incorporated (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...For example, the Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) share price is up 90% in the last 5 years, clearly besting the market return of around 56% (ignoring dividends).Get the latest VRTX stock quote, history, news and other vital information to help you with your stock trading and investing. Vertex is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases, including cystic fibrosis, beta thalassemia, sickle-cell disease, and type 1 diabetes.Instagram:https://instagram. cnhi industrialsliding in insurancebest banks for va loanstop rated 529 plans The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry. There are 17 Sectors, 60 different M Industries, and 265 X ...Abrahams has a sector perform rating on VRTX stock, but raised his price target to 343 from 325. ... VRTX stock analysts had predicted adjusted earnings of $14.56 per share and $9.76 billion in sales. who has mounjaro in stockget paid to drive tesla According to 17 Wall Street analysts that have issued a 1 year VRTX price target, the average VRTX price target is $380.77, with the highest VRTX stock price ... glgd stock VRTX stock chart by TradingView. OTC: VTECF. Track all markets on TradingView. FRA: AA3. AA3 stock chart by TradingView. Company Profile. 778-819-0164; ... AA3 stock chart by TradingView. Company Profile. 778-819-0164; [email protected]; 1177 W Hastings St Vancouver BC; Download Presentation. Projects. Vortex Salt;Nov 24, 2023 · Analyzing VRTX Stock Performance. On Wednesday, Vertex Pharmaceuticals, Inc. [NASDAQ: VRTX] plunged -0.44% to $353.23. The stock’s lowest price that day was $350.0269, but it reached a high of $358.50 in the same session. During the last five days, there has been a surge of approximately 1.11%.